Liquid Biopsy: A Multi-Parametric Analysis of Mutation Status, Circulating Tumor Cells and Inflammatory Markers in EGFR-Mutated NSCLC

The liquid biopsy has the potential to improve patient care in the diagnostic and therapeutic setting in non-small cell lung cancer (NSCLC). Consented patients with epidermal growth factor receptor (EGFR) positive disease (n = 21) were stratified into two cohorts: those currently receiving EGFR tyro...

Descripción completa

Detalles Bibliográficos
Autores principales: Barr, Martin P., Baird, Anne-Marie, Halliday, Sophia, Martin, Petra, Allott, Emma H., Phelan, James, Korpanty, Greg, Coate, Linda, O’Brien, Cathal, Gray, Steven G., Sui, Jane S. Y., Hayes, Brian, Cuffe, Sinead, Finn, Stephen P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600124/
https://www.ncbi.nlm.nih.gov/pubmed/36292049
http://dx.doi.org/10.3390/diagnostics12102360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600124/
https://www.ncbi.nlm.nih.gov/pubmed/36292049
http://dx.doi.org/10.3390/diagnostics12102360

Ejemplares similares